-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
VYNE Therapeutics Inc. quarterly/annual General and Administrative Expense history and growth rate from 2015 to Q2 2025.
- VYNE Therapeutics Inc. General and Administrative Expense for the quarter ending June 30, 2025 was $2.73M, a 17% decline year-over-year.
- VYNE Therapeutics Inc. General and Administrative Expense for the twelve months ending June 30, 2025 was $12.1M, a 13.1% decline year-over-year.
- VYNE Therapeutics Inc. annual General and Administrative Expense for 2024 was $13.2M, a 1.37% decline from 2023.
- VYNE Therapeutics Inc. annual General and Administrative Expense for 2023 was $13.4M, a 18.4% decline from 2022.
- VYNE Therapeutics Inc. annual General and Administrative Expense for 2022 was $16.4M.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)